Benzinga's Top Upgrades, Downgrades For September 2, 2020

Upgrades

  • For Zillow Group Inc ZG, Deutsche Bank upgraded the previous rating of Hold to the current rating Buy. In the second quarter, Zillow Gr showed an EPS of $0.41, compared to $0.14 from the year-ago quarter. At the moment, the stock has a 52-week-high of $88.82 and a 52-week-low of $18.65. Zillow Gr closed at $88.26 at the end of the last trading period.
  • Berenberg upgraded the previous rating for Southwest Airlines Co LUV from Hold to Buy. For the second quarter, Southwest Airlines had an EPS of $2.67, compared to year-ago quarter EPS of $1.37. The current stock performance of Southwest Airlines shows a 52-week-high of $58.83 and a 52-week-low of $22.46. Moreover, at the end of the last trading period, the closing price was at $37.92.
  • RBC Capital upgraded the previous rating for Equitable Holdings Inc EQH from Sector Perform to Outperform. For the second quarter, Equitable Holdings had an EPS of $1.00, compared to year-ago quarter EPS of $1.14. The current stock performance of Equitable Holdings shows a 52-week-high of $27.30 and a 52-week-low of $9.89. Moreover, at the end of the last trading period, the closing price was at $21.10.

 

Downgrades

  • According to Credit Suisse, the prior rating for Youdao Inc DAO was changed from Outperform to Neutral. In the second quarter, Youdao earned $0.33. The stock has a 52-week-high of $47.70 and a 52-week-low of $12.01. At the end of the last trading period, Youdao closed at $32.19.
  • Loop Capital downgraded the previous rating for Wanda Sports Group Co Ltd WSG from Buy to Hold. Wanda Sports Group Co earned $0.05 in the second quarter, compared to $0.19 in the year-ago quarter. At the moment, the stock has a 52-week-high of $5.35 and a 52-week-low of $1.36. Wanda Sports Group Co closed at $2.11 at the end of the last trading period.
  • According to Berenberg, the prior rating for American Airlines Group Inc AAL was changed from Hold to Sell. In the second quarter, American Airlines Group showed an EPS of $7.82, compared to $1.82 from the year-ago quarter. The current stock performance of American Airlines Group shows a 52-week-high of $31.67 and a 52-week-low of $8.25. Moreover, at the end of the last trading period, the closing price was at $13.10.
  • For Delta Air Lines Inc DAL, Berenberg downgraded the previous rating of Buy to the current rating Hold. Delta Air Lines earned $4.43 in the second quarter, compared to $2.35 in the year-ago quarter. At the moment, the stock has a 52-week-high of $62.48 and a 52-week-low of $17.51. Delta Air Lines closed at $30.71 at the end of the last trading period.

 

Initiations

  • With a current rating of Outperform, Barrington Research initiated coverage on Franchise Group Inc FRG. The price target seems to have been set at $33.00 for Franchise Group. Franchise Group earned $0.53 in the second quarter. At the moment, the stock has a 52-week-high of $27.49 and a 52-week-low of $5.75. Franchise Group closed at $25.09 at the end of the last trading period.
  • For Ionis Pharmaceuticals Inc IONS, Benchmark initiated coverage, by setting the current rating at Hold. In the second quarter, Ionis Pharmaceuticals showed an EPS of $0.23, compared to $0.01 from the year-ago quarter. The stock has a 52-week-high of $67.31 and a 52-week-low of $39.32. At the end of the last trading period, Ionis Pharmaceuticals closed at $54.27.
  • With a current rating of Hold, Truist Securities initiated coverage on DraftKings Inc DKNG. The price target seems to have been set at $39.00 for DraftKings. DraftKings earned $0.55 in the second quarter, compared to $0.15 in the year-ago quarter. The stock has a 52-week-high of $44.79 and a 52-week-low of $18.00. At the end of the last trading period, DraftKings closed at $36.93.
  • William Blair initiated coverage on Nautilus Inc NLS with an Outperform rating. For the second quarter, Nautilus had an EPS of $0.56, compared to year-ago quarter EPS of $0.25. The stock has a 52-week-high of $15.91 and a 52-week-low of $1.20. At the end of the last trading period, Nautilus closed at $13.85.
  • With a current rating of Neutral, Baird initiated coverage on BioTelemetry Inc BEAT. The price target seems to have been set at $43.00 for BioTelemetry. In the second quarter, BioTelemetry showed an EPS of $0.35, compared to $0.53 from the year-ago quarter. The current stock performance of BioTelemetry shows a 52-week-high of $55.85 and a 52-week-low of $27.35. Moreover, at the end of the last trading period, the closing price was at $39.75.
  • With a current rating of Buy, Jefferies initiated coverage on New Oriental Education & Technology Group Inc EDU. The price target seems to have been set at $175.00 for New Oriental Education. New Oriental Education earned $0.30 in the fourth quarter, compared to $0.60 in the year-ago quarter. The current stock performance of New Oriental Education shows a 52-week-high of $153.02 and a 52-week-low of $102.01. Moreover, at the end of the last trading period, the closing price was at $151.01.
  • With a current rating of Outperform, Baird initiated coverage on Hill-Rom Holdings Inc HRC. The price target seems to have been set at $115.00 for Hill-Rom Holdings. For the third quarter, Hill-Rom Holdings had an EPS of $1.95, compared to year-ago quarter EPS of $1.23. At the moment, the stock has a 52-week-high of $117.68 and a 52-week-low of $72.29. Hill-Rom Holdings closed at $92.50 at the end of the last trading period.
  • With a current rating of Outperform, Baird initiated coverage on Inspire Medical Systems Inc INSP. The price target seems to have been set at $130.00 for Inspire Medical Systems. In the second quarter, Inspire Medical Systems showed an EPS of $0.88, compared to $0.32 from the year-ago quarter. The stock has a 52-week-high of $124.65 and a 52-week-low of $40.53. At the end of the last trading period, Inspire Medical Systems closed at $123.89.
  • With a current rating of Neutral, Baird initiated coverage on iRhythm Technologies Inc IRTC. The price target seems to have been set at $220.00 for iRhythm Technologies. In the second quarter, iRhythm Technologies showed an EPS of $0.75, compared to $0.46 from the year-ago quarter. The current stock performance of iRhythm Technologies shows a 52-week-high of $232.58 and a 52-week-low of $56.24. Moreover, at the end of the last trading period, the closing price was at $226.70.
  • Baird initiated coverage on Intuitive Surgical Inc ISRG with a Neutral rating. The price target for Intuitive Surgical is set to $700.00. In the second quarter, Intuitive Surgical showed an EPS of $1.11, compared to $3.25 from the year-ago quarter. The current stock performance of Intuitive Surgical shows a 52-week-high of $742.44 and a 52-week-low of $360.50. Moreover, at the end of the last trading period, the closing price was at $741.57.
  • Baird initiated coverage on LivaNova PLC LIVN with an Outperform rating. The price target for LivaNova is set to $55.00. For the second quarter, LivaNova had an EPS of $0.15, compared to year-ago quarter EPS of $0.70. The current stock performance of LivaNova shows a 52-week-high of $87.45 and a 52-week-low of $33.40. Moreover, at the end of the last trading period, the closing price was at $46.05.
  • Baird initiated coverage on Masimo Corp MASI with an Outperform rating. The price target for Masimo is set to $260.00. Masimo earned $0.85 in the second quarter, compared to $0.76 in the year-ago quarter. At the moment, the stock has a 52-week-high of $258.00 and a 52-week-low of $139.36. Masimo closed at $223.65 at the end of the last trading period.
  • With a current rating of Outperform, Baird initiated coverage on Nevro Corp NVRO. The price target seems to have been set at $160.00 for Nevro. For the second quarter, Nevro had an EPS of $1.21, compared to year-ago quarter EPS of $0.91. The current stock performance of Nevro shows a 52-week-high of $148.05 and a 52-week-low of $65.05. Moreover, at the end of the last trading period, the closing price was at $143.38.
  • Jefferies initiated coverage on BioXcel Therapeutics Inc BTAI with a Buy rating. The price target for BioXcel Therapeutics is set to $82.00. BioXcel Therapeutics earned $1.06 in the second quarter, compared to $0.54 in the year-ago quarter. The stock has a 52-week-high of $71.50 and a 52-week-low of $3.76. At the end of the last trading period, BioXcel Therapeutics closed at $40.75.
Posted In: AirlinesHealth CareHealth Care EquipmentIndustrialsInitiationstop upgradesPenny StocksUpgradesDowngradesInitiationIntraday UpdateAnalyst Ratings